A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: procedure (650), etiquette (1), practice (609)

Afatinib Ver 1

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Regimen AFATINIB NSCLC - Afatinib Indication Treatment of locally advanced or metastatic non-small
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/AfatinibVer1.pdf

Vinblastine Ver 1.1

Description
Chemotherapy Protocol LYMPHOMA VINBLASTINE Regimen Lymphoma – Vinblastine Indication Non-Hodgkin’s Lymphoma Hodgkin’s Lymphoma Toxicity Drug Vinblastine Adverse Effect Peripheral
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Vinblastine-Ver-1.1.pdf

Rituximab (weekly)

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB (weekly) Regimen Lymphoma – Rituximab (weekly) Indication CD20 positive indolent non Hodgkin’s lymphoma. Toxicity Drug Rituxumab Adverse
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-weekly.pdf

Rituximab (3 weekly)

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB (3 Weekly) Regimen Lymphoma – Rituximab (3 weekly) Indication Non Hodgkin’s Lymphoma in combination with chemotherapy Toxicity
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-3-weekly.pdf

Nordic 3000

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-CYTARABINE-DOXORUBICIN-PREDNISOLONE-RITUXIMABVINCRISTINE (Nordic 3000) Inpatient-Outpatient Regimen There are multiple versions of this protocol in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Nordic-3000.pdf

Nordic_2000

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-CYTARABINE-DOXORUBICIN-PREDNISOLONE-RITUXIMABVINCRISTINE (Nordic 2000) Inpatient-Outpatient Regimen There are multiple versions of this protocol in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Nordic-2000.pdf

Ibrutinib (WM) (420mg)

Description
Chemotherapy Protocol Waldenström's Macroglobulinaemia (WM) Regimen Ibrutinib • WM – Ibrutinib (420mg) Indication • The treatment of adult patients with Waldenström's Macroglobulinaemia (WM) who
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Ibrutinib-WM-420mg.pdf

Trabectedin v1

Description
Chemotherapy Protocol SARCOMA Regimen TRABECTEDIN Sarcoma-Trabectedin Indication Trabectedin is recommended as a possible treatment for people with advanced soft tissue
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Trabectedin-v1.pdf

MifamurtideVer1.1

Description
Chemotherapy Protocol SARCOMA MIFAMURTIDE Regimen Sarcoma-Mifamurtide Indication Children, adolescents and young adults (30 years of age or less) with osteosarcoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/MifamurtideVer1.1.pdf

Imatinib v1

Description
Chemotherapy Protocol SARCOMA Gastro-Intestinal Stromal Tumour (GIST) Imatinib Regimen GIST-Imatinib Indication Imatinib is recommended as a possible adjuvant treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Imatinib-v1.pdf
251 to 260 of 698
Previous … 24 25 26 27 28 … Next